麻豆传媒色情片

Annual Meeting

Scientists see anti-aging potential in an invasive weed

Cocklebur extracts could protect skin, speed wound healing and ward off wrinkles
Anne Frances Johnson
March 29, 2023

The fruit of the cocklebur plant, which grows worldwide and is often considered a noxious weed, has antioxidant and anti-inflammatory components that could make it useful as a skin protectant, according to new research.

Researchers found that compounds in the species’ spiky fruits reduced damage from UVB exposure and sped wound healing in laboratory tests using cells and tissues. The cocklebur extracts also appear to influence the production of collagen, a protein that gives skin its elasticity and prevents wrinkles.

“We found that cocklebur fruit has the potential to protect the skin and help enhance production of collagen,” said Eunsu Song, a doctoral candidate at Myongji University in South Korea, who conducted the research with Myongji University Professsor Jinah Hwang. “In this regard, it could be an attractive ingredient for creams or other cosmetic forms. It will likely show a synergistic effect if it is mixed with other effective compounds, such as hyaluronic acid or retinoic acid, against aging.”

Xanthium (cocklebur) is native to the Americas and eastern Asia.

Song will present the new research at , the annual meeting of the 麻豆传媒色情片 and 麻豆传媒色情片 Biology, March 25–28 in Seattle.

Cocklebur is a plant native to Southern Europe, Central Asia and China that has spread worldwide, often found in moist or sandy areas such as roadside ditches and riverbanks. Its distinctive fruits, covered in stiff husks and burrs, have been used for centuries in traditional medicines for headache, stuffy nose, disorders of skin pigmentation, tuberculosis-related illness and rheumatoid arthritis. In recent years scientists have explored its potential use in treatments for rheumatoid arthritis and cancer.

The new study is the first to examine the fruit’s properties as a wound-healing agent and skin protectant. Researchers first studied the molecular properties of cocklebur fruit extracts and isolated particular compounds that could contribute to anti-oxidant and anti-inflammatory effects. They then used cell cultures and a 3D tissue model with properties similar to human skin to study how these compounds affect collagen production, wound healing and damage from UVB radiation.

The results showed that the cocklebur fruit extracts encouraged collagen production, sped wound healing and exerted a protective effect against UVB radiation. Comparing the bioactivity of cocklebur fruits grown in different places, the researchers found that fruits grown in South Korea had slightly higher anti-oxidant and anti-inflammatory properties and greater wound-healing activity than those grown in China.

Researchers cautioned that high doses of cocklebur fruit extract can be harmful and further research is needed to determine how to use it safely in cosmetic or pharmaceutical applications.

“In its burrs, cocklebur fruit also has a toxic constituent, carboxyatractyloside, which can damage the liver,” said Song. “Cocklebur showed a potential as a cosmetic agent by increasing collagen synthesis; however, it showed negative results with higher concentrations. Therefore, finding the proper concentration seems very important and would be key to commercializing cocklebur fruit extracts in cosmetics.”

Moving forward, the researchers plan to further study the biological mechanisms involved and conduct experiments in animal alternatives to explore ways to safely adapt cocklebur fruit extracts for use in cosmetic products.

Eunsu Song will present this research during the poster session from 4–5:30 p.m. PDT on Tuesday, March 28, in the Exhibit Hall of the Seattle Convention Center () (Poster Board No. 139). Contact the media team for more information or to obtain a free press pass to attend the meeting.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Anne Frances Johnson

Anne Frances Johnson is founder and lead science writer at based in Chapel Hill, North Carolina. 

Get the latest from ASBMB Today

Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto鈥揜yu鈥揗alicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer鈥檚 spaghetti proteins
Profile

Unraveling cancer鈥檚 spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting 鈥渦ndruggable鈥 molecules.

How HCMV hijacks host cells 鈥 and beyond
Profile

How HCMV hijacks host cells 鈥 and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Profile

Understanding the lipid link to gene expression in the nucleus

Aug. 11, 2025

Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.

Receptor antagonist reduces age-related bone loss in mice
Journal News

Receptor antagonist reduces age-related bone loss in mice

Aug. 6, 2025

Receptor antagonist reduces bone loss and promotes osteoblast activity in aging mice, highlighting its potential to treat osteoporosis. Read more about this recent JBC paper.

Engineered fusion protein targets kiwifruit pathogen
Journal News

Engineered fusion protein targets kiwifruit pathogen

Aug. 6, 2025

Synthetic protein selectively kills kiwifruit pathogen, offering a promising biocontrol strategy for agriculture. Read more about this recent JBC paper.